Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957736 · ClinicalTrials.gov registry record
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- 252
- Enrollment target
NCT00957736 is a clinical trial that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 252 participants.
The verdict
NCT00957736 was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- 252 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to chronic graft-versus-host disease in patients who have undergone donor stem cell transplant. PURPOSE: This phase I trial is studying chronic graft-versus-host disease in patients who have undergone donor stem cell transplant.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00957736
The ClinicalTrials.gov registry entry for NCT00957736 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00957736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00957736 about?
NCT00957736 is a clinical study titled "Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant". RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to chronic graft-versus-host disease in patients who have undergone donor stem cell transplant. PURPOSE: This phase I trial i...
What is the current status of trial NCT00957736?
This trial is currently terminated. The enrollment target is 252 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00957736?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00957736?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.